Michael J. Farrell
At a glance: Michael J. Farrell is CEO, Chair at ResMed (RMD). Their latest SEC Form 4, filed Nov 12, 2026, reported a sale of $1.2M. On file: 0 purchase lines ($0) and 14 sale lines ($18.0M).
Disclosed holdings: about $114M of RMD stock: 479,803 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 19, 2026 close of $237.09. This counts only RMD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO at Resmed Inc (RMD); CEO, Chair at Resmed Inc (RMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Michael J. Farrell's InsiderPrint
14 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 13 times a year, typically $1.2M a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (14)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Aaron JagdfeldCEO · GNRC · 100% match
- David M. RothensteinEvp & Chief Strategy Officer · CIEN · 100% match
- Salvatore A. MiosiCOO, President · MTG · 100% match
- Joseph M. ErlingerPresident · MCD · 100% match
- Mark KiddEvp, Gm Data Centers & Alm · IRM · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | RMDResmed Inc | Sell Plan | 4,993479,803 held (−1%) | $235.35 | $1.2M | +0.7% |
| Oct 8SEC | RMDResmed Inc | Sell Plan | 4,991479,803 held (−1%) | $226.33 | $1.1M | +4.7% |
| Sep 10SEC | RMDResmed Inc | Sell Plan | 4,991466,256 held (−1%) | $222.44 | $1.1M | +6.6% |
| Aug 11SEC | RMDResmed Inc | Sell Plan | 4,991466,256 held (−1%) | $205.69 | $1.0M | +15.3% |
| Jul 9SEC | RMDResmed Inc | Sell Plan | 4,991466,223 held (−1%) | $218.55 | $1.1M | +8.5% |
| Jun 9SEC | RMDResmed Inc | Sell Plan | 4,991466,256 held (−1%) | $193.96 | $968K | +22.2% |
| May 11SEC | RMDResmed Inc | Sell Plan | 4,991466,223 held (−1%) | $207.82 | $1.0M | +14.1% |
| Apr 9SEC | RMDResmed Inc | Sell Plan | 4,991466,223 held (−1%) | $225.50 | $1.1M | +5.1% |
| Mar 11SEC | RMDResmed Inc | Sell Plan | 4,991466,223 held (−1%) | $251.03 | $1.3M | -5.6% |
| Feb 10SEC | RMDResmed Inc | Sell Plan | 4,991466,223 held (−1%) | $273.78 | $1.4M | -13.4% |
| Jan 8SEC | RMDResmed Inc | Sell Plan | 4,991466,223 held (−1%) | $248.46 | $1.2M | -4.6% |
| Dec 9SEC | RMDResmed Inc | Sell Plan | 4,991466,223 held (−1%) | $251.41 | $1.3M | -5.7% |
| Nov 10SEC | RMDResmed Inc | Sell Plan | 8,011467,866 held (−2%) | $249.75 | $2.0M | -5.1% |
| Oct 9SEC | RMDResmed Inc | Sell Plan | 8,009467,792 held (−2%) | $282.85 | $2.3M | -16.2% |
- Sell
CEO, Chair Michael J. Farrell sold $1.2M of RMD at $235.35 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Michael J. Farrell sold $1.1M of RMD at $226.33 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Michael J. Farrell sold $1.1M of RMD at $222.44 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Michael J. Farrell sold $1.0M of RMD at $205.69 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Michael J. Farrell sold $1.1M of RMD at $218.55 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Michael J. Farrell sold $968K of RMD at $193.96 — pre-scheduled 10b5-1 plan sale.
Follow Michael J. Farrell
Get one email when Michael J. Farrell files a new purchase or sale. Free.
At most one email a day about Michael J. Farrell, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.